Clinical trial
Study to Evaluate the Safety and Immunogenicity of Fluarix™ 2006/2007 in Adults…
NCT00345904 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00345904 |
|---|---|
| Title | Study to Evaluate the Safety and Immunogenicity of Fluarix™ 2006/2007 in Adults Aged 18 Years or Above |
| Official title | A Phase III Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix™ (Influsplit SSW®) 2006/2007 in People Aged 18 Years or Above |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | Fluarix |
| Enrollment | 120 |
| Start date | Jul 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Jun 29, 2006 |
| Last update posted | Sep 28, 2016 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: